Open company graph database — free web & API
Login

Astellas Pharmaceuticals AEBE

Ticker
—
Listed market
—
Country
Japan
Employees (non-consolidated)
—
Related companies
23
§01

Basic information

BASIC
Head office
Tokyo
Chief executive
Naoki Okamura
Capital
Employees (non-consolidated)
Employees (consolidated)
Start date
End date
§02

Websites

1 DOMAINS
§03

Business

5
Products and Disease AreasRx+ Business CreationProductsPipelineDigital Health Solutions
§04

Related companies

23 COMPANIES
Company name Group Parent Subsidiary Customer Supplier Alliance Bank Shareholder
Astellas Pharma Europe Ltd.
Group Subsidiary
Exio Group Inc.
Group
National Institute of Advanced Industrial Science and Technology
Group
Takeda Teba Pharmaceutical Co., Ltd.
Group
TRE Holdings Co., Ltd.
Group
Avara Norman Pharmaceutical Services, Inc.
Group
Nippon Medical & Pharmaceutical Co., Ltd.
Group
OSI Pharmaceuticals, Inc
Group Subsidiary
OSI Pharmaceuticals社
Group Subsidiary
Takeda Pharmaceutical Company, Limited
Group
アステラス ファーマ グローバル ディベロップメント Inc.
Group Subsidiary
アステラス ファーマ ヨーロッパ B.V.
Group Subsidiary
アステラス ファーマ ヨーロッパ Ltd.
Group Subsidiary
アストレージ社
Group
レゾナック・ホールディングス
Group
Astellas Pharma Canada, Inc.
Customer
Astellas Pharma Philippines, Inc.
Customer
Astellas Pharma US, Inc.
Customer
Astellas Pharma Inc.
Customer
Beijing Astellas Pharma Co., Ltd.
Customer
Ansell (China) Investment Co., Ltd. Shanghai Branch
Customer
Ansell Pharmaceutical (China) Co., Ltd.
Customer
Yusui BV Japan Inc.
Supplier
Names without a link are companies not yet registered in OpenBizGraph
§05

Network

NETWORK
Drag to move · click to open
§06

History

10 EVENTS

Founded in 1894Sources

Founded in 1923Sources

Kenji Yamanouchi founded Yamanouchi Pharmaceutical & Trading Company in Osaka in 1940, and the company was renamed Yamanouchi Pharmaceutical Co., Ltd.Sources

Renamed to Yamanouchi Pharmaceutical Co., Ltd. in 1940Sources

Relocated headquarters to Tokyo in 1942Sources

Relocated headquarters to Tokyo in 1942Sources

Established in April 2005 through the merger of Yamanouchi Pharmaceutical, founded in 1923, and Fujisawa Pharmaceutical, founded in 1894. The merger combined Yamanouchi's strengths in urology and synthetic technology with Fujisawa's strengths in transplantation, immunology, and fermentation technology, forming an optimal partnership that complements each other.Sources

Astellas was established in April 2005 through the merger of Yamanouchi Pharmaceutical and Fujisawa PharmaceuticalSources

Astellas Pharma celebrated its 20th anniversary in April 2025.Sources

Astellas Pharma celebrated its 20th anniversary in April 2025Sources

§07

News

0 ARTICLES

There is no news.

§09

Sources & updates

SOURCES
↑